Table S2 from Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML
Authors:
- Hiroshi UreshinoHUHiroshi Ureshino
- Takero ShindoTSTakero Shindo
- Hiroto KojimaHKHiroto Kojima
- Yasushi KusunokiYKYasushi Kusunoki
- Yuki MiyazakiYMYuki Miyazaki
- Hidenori TanakaHTHidenori Tanaka
- Hiroh SajiHSHiroh Saji
- Atsushi KawaguchiAKAtsushi Kawaguchi
- Shinya KimuraSKShinya Kimura
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)